Pfizer Misses Profit Targets
First-quarter earnings take a hit from generic-drug competition, but the drugmaker reaffirms full-year guidance. 5 months ago
TheStreet Click here to Read the Full StoryFirst-quarter earnings take a hit from generic-drug competition, but the drugmaker reaffirms full-year guidance. 5 months ago
TheStreet Click here to Read the Full Story